Sign in

CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(919) 636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,310,718
in 4 filings, $1.2M under 10b5-1 plans

Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-03 Brughera Marco Maria Director Grant or award · Stock Option +20,000 $7.88 $158K 215,545
2025-06-03 RALLIS CHRIS A Director Grant or award · Stock Option +20,000 $7.88 $158K 200,533
2025-06-03 Islam Khalid Director Grant or award · Stock Option +25,000 $7.88 $197K 225,000
2025-05-31 Raykov Rosty Director Grant or award +5,208 75,462
2025-05-31 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +2,431 160,951
2025-05-22 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise +8,220 $5.10 $42K 158,520
2025-05-22 Andrade Robert CHIEF FINANCIAL OFFICER Option exercise · Stock Options −8,220 $5.10 $42K 850,751
2025-05-19 Hackman Jeffrey S. Chief Executive Officer Purchase +13,965 $6.99 $98K 15,000
2025-05-16 Hackman Jeffrey S. Chief Executive Officer Purchase +1,035 $6.75 $7K 1,035
2025-05-16 Raykov Rosty Director Grant or award +33,334 86,921
2025-05-16 Raykov Rosty Director Sale −16,667 $6.78 $113K 70,254
2025-05-16 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +16,667 150,300
2025-05-05 Raykov Rosty Director Sale 10b5-1 −10,000 $6.31 $63K 53,587
2025-04-30 Andrade Robert CHIEF FINANCIAL OFFICER Grant or award +1,042 133,633
2025-04-30 Raykov Rosty Director Grant or award +2,431 63,587
2025-04-11 RALLIS CHRIS A Director Option exercise 10b5-1 +2,173 $2.30 $5K 55,193
2025-04-11 RALLIS CHRIS A Director Sale 10b5-1 −1,409 $4.95 $7K 53,784
2025-04-11 RALLIS CHRIS A Director Option exercise · Common Shares 10b5-1 −2,173 $2.30 $5K 180,533
2025-04-04 Raykov Rosty Director Sale 10b5-1 −10,000 $5.25 $53K 61,156
2025-03-31 Raykov Rosty Director Grant or award +2,431 71,156

Page 9 of 17 · 340 trades